PRACTICAL SYNTHETIC PROCEDURES
One-Pot Synthesis of 1,3-Thiazoles
3445
Anal. Calcd for C16H11Cl2NS: C, 60.01; H, 3.46; N, 4.37; S, 10.01.
Found: C, 59.51; H, 3.27; N, 4.34; S, 10.27.
HRMS (EI): m/z calcd for C20H20BrNS: 385.04998; found:
385.0500.
5-(4-Chlorophenyl)-2-(4-methoxyphenyl)-4-methylthiazole (4k)
Yield: 12 mg (22%); white solid; mp 120 °C.
4-Methyl-5-(naphthalen-2-yl)-2-phenylthiazole (4q)
Yield: 18 mg (35%); white solid; mp 130 °C.
1H NMR (300 MHz, CDCl3): δ = 8.31(d, J = 9.0 Hz, 1 H), 7.98 (d,
J = 9.0 Hz, 1 H), 7.86 (d, J = 9.0 Hz, 2 H), 6.97–6.91 (dd, J = 9.0,
15 Hz, 4 H), 3.84 (s, 3 H), 2.50 (s, 3 H).
13C NMR (75 MHz, CDCl3): δ = 164.8, 162.0, 160.7, 160.6, 148.3,
133.1, 131.5, 129.4, 129.1, 128.3, 127.1, 125.0, 114.1, 113.5, 55.0,
15.9.
1H NMR (300 MHz, CDCl3): δ = 7.93–7.85 (m, 6 H), 7.61 (d, J =
3.0 Hz, 2 H), 7.53–7.49 (m, 4 H), 2.62 (s, 3 H).
13C NMR (100 MHz, CDCl3): δ = 164.8, 148.6, 133.2, 132.8, 132.1,
131.9, 129.4, 129.1, 128.4, 127.9, 127.6, 127.5, 127.3, 126.6, 126.2,
126.0, 125.9, 16.1.
MS (EI): m/z = 301 (100%, M + H+).
MS (EI): m/z = 315 (100%, M+).
HRMS (EI): m/z calcd for C20H15NS: 301.0915; found: 301.0925.
HRMS (EI): m/z calcd for C17H14ClNOS: 315.04846; found:
315.0485.
2-(4-Chlorophenyl)-4-methyl-5-(naphthalen-2-yl)thiazole (4r)
Yield: 17 mg (30%); white solid; mp 160 °C.
1H NMR (300 MHz, CDCl3): δ = 7.90–7.87 (m, 6 H), 7.59–7.51 (m,
3 H), 7.41 (d, J = 6.0 Hz, 2 H), 2.61 (s, 3 H).
13C NMR (75 MHz, CDCl3): δ = 163.4, 148.8, 135.3, 134.7, 132.8,
132.2, 132.1, 131.7, 128.9, 128.7, 128.0, 127.7, 127.6, 127.3, 127.0,
126.5, 126.3, 126.1, 16.0.
5-(4-Methoxyphenyl)-4-methyl-2-phenylthiazole (4l)
Yield: 11 mg (30%); white solid; mp 70 °C.
1H NMR (300 MHz, CDCl3): δ = 7.93 (d, J = 6.0 Hz, 2 H), 7.42–
7.38 (m, 4 H), 6.97 (d, J = 3.0 Hz, 2 H), 3.84 (s, 3 H), 2.52 (s, 3 H).
13C NMR (75 MHz, CDCl3): δ = 164.0, 156.5, 150.4, 133.4, 131.5,
129.4, 129.1, 128.3, 127.1, 125.0, 120.0, 110.7, 55.1, 15.9.
MS (EI): m/z = 281 (100%, M+).
MS (EI): m/z = 335 (100%, M+).
2-(4-tert-Butylphenyl)-4-methyl-5-(naphthalen-2-yl)thiazole
(4s)
5-(2-Methoxyphenyl)-4-methyl-2-phenylthiazole (4m)
Yield: 11 mg (31%); white solid; mp 69 °C.
Yield: 19 mg (32%); white solid; mp 137 °C.
1H NMR (300 MHz, CDCl3): δ = 7.87–7.61 (m, 6 H), 7.60 (d, J =
6.0 Hz, 1 H), 7.57–7.49 (m, 3 H), 7.47 (d, J = 12.0 Hz, 1 H), 2.62
(s, 3 H), 1.34 (s, 9 H).
13C NMR (75 MHz, CDCl3): δ = 165.0, 152.7, 148.5, 140.9, 132.8,
132.0, 131.3, 130.5, 129.3, 127.9, 127.6, 127.5, 127.2, 126.6, 126.2,
125.9, 125.6, 125.4, 34.4, 30.7, 16.1.
1H NMR (300 MHz, CDCl3): δ = 7.93 (d, J = 6.0 Hz, 2 H), 7.41–
7.33 (m, 4 H), 7.04–6.99 (m, 2 H), 3.84 (s, 3 H), 2.41 (s, 3 H).
13C NMR (75 MHz, CDCl3): δ = 165.5, 156.5, 150.2, 133.4, 131.5,
129.3, 129.1 128.3, 127.1, 125.8, 120.2, 120.0, 110.7, 55.1, 15.9.
MS (EI): m/z = 281 (100%, M+).
MS (EI): m/z = 357 (100%, M+).
2-(4-tert-Butylphenyl)-5-(4-methoxyphenyl)-4-methylthiazole
(4n)
Yield: 14 mg (33%); white solid, mp 80 °C.
2-(4-Methoxyphenyl)-4-methyl-5-(naphthalen-2-yl)thiazole (4t)
Yield: 18 mg (33%); white solid; mp 119 °C.
1H NMR (300 MHz, CDCl3): δ = 8.51–8.46 (m, 6 H), 8.20–8.10 (m,
3 H), 7.57–7.53 (m, 2 H), 4.46 (s, 3 H), 3.21 (s, 3 H).
1H NMR (300 MHz, CDCl3): δ = 7.86 (d, J = 6.0 Hz, 2 H), 7.43 (d,
J = 6.0 Hz, 2 H), 7.35 (d, J = 6.0 Hz, 2 H), 7.03 (m, 2 H), 3.84 (s, 3
H), 2.40 (s, 3 H), 1.33 (s, 9 H).
13C NMR (75 MHz, CDCl3): δ = 165.6, 156.5, 152.4, 150.3, 131.5,
130.8, 129.2, 126.6, 125.6, 120.4, 120.0, 110.7, 55.1, 34.4, 30.7,
16.0.
13C NMR (100 MHz, CDCl3): δ = 135.0, 133.0, 132.0, 131.9, 131.0,
129.3, 128.7, 127.9, 127.5, 127.3, 127.2, 126.6, 126.3, 126.2, 126.1,
125.9, 113.8, 54.9.
MS (EI): m/z = 337 (100%, M+).
MS (EI): m/z (%) = 331 (80, M+), 298(100).
HRMS (EI): m/z calcd for C21H23NOS: 337.1488; found: 337.1500.
Acknowledgment
2-(4-tert-Butylphenyl)-5-(2-methoxyphenyl)-4-methylthiazole
(4o)
The authors gratefully acknowledge generous financial support
from the Deutsche Forschungsgemeinschaft and the BMBF (DLR,
Project MDA 08/010).
Yield: 10 mg (24%); white solid; mp 93 °C.
1H NMR (300 MHz, CDCl3): δ = 7.43 (d, J = 6.0 Hz, 2 H), 7.41 (d,
J = 3.0 Hz, 2 H), 7.35 (d, J = 3.0 Hz, 2 H), 7.03 (m, 2 H), 3.84 (s, 3
H), 2.41 (s, 3 H), 1.33 (s, 9 H).
References
13C NMR (75 MHz, CDCl3): δ = 165.6, 156.5, 152.4, 150.0, 131.5,
130.8, 129.2, 126.6, 125.6, 125.3, 120.4, 120.0, 110.7, 55.1, 34.4,
30.8, 15.9.
(1) Mullins, R. J.; Azman, A. M. Palladium in Heterocyclic
Chemistry; Vol. 26; Li, J. J.; Gribble, G. W., Eds.;
Tetrahedron Organic Chemistry Series; Elsevier: Oxford,
2007, 345.
(2) Campbell, M. M. Comprehensive Organic Chemistry; Vol.
4; Barton, D. H. R.; Ollis, W. D., Eds.; Pergamon Press:
London, 1979, 961.
(3) Dondini, A. Org. Biomol. Chem. 2010, 8, 3366.
(4) (a) Trumm, K. A.; Sattler, H. J.; Postius, S.; Szelenyi, I.;
Schunack, W. Arzneim. Forsch. 1985, 35, 573. (b) Kempf,
D. J.; Sham, H. L.; Marsh, K. C.; Flentge, C. A.; Betebenner,
D.; Green, B. E.; McDonald, E.; Vasavanonda, S.; Saldivar,
A.; Wideburg, N. E.; Kati, W. M.; Ruiz, L.; Zhao, C.; Fino,
MS (EI): m/z = 337 (100%, M+).
2-(4-tert-Butylphenyl)-5-(4-bromophenyl)-4-methylthiazole
(4p)
Yield: 27 mg (41%); white solid; mp 100 °C.
1H NMR (300 MHz, CDCl3): δ = 7.85 (d, J = 3.0 Hz, 2 H), 7.82 (d,
J = 3.0 Hz, 2 H), 7.54 (d, J = 9.0 Hz, 2 H), 7.30 (d, J = 9.0 Hz, 2 H),
2.51 (s, 3 H), 1.33 (s, 9 H).
13C NMR (75 MHz, CDCl3): δ = 165.0, 152.9, 148.5, 131.4, 130.8,
130.4, 129.9, 125.6, 125.4, 121.3, 34.4, 30.7, 30.7, 16.0.
MS (EI) m/z (%) = 385 (50, M+), 372 (100).
© Georg Thieme Verlag Stuttgart · New York
Synthesis 2012, 44, 3441–3446